Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac versus methylprednisolone subacromial injection for shoulder impingement syndrome
IRCT20230625058584N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ketorolac and methylprednisolone in rotator cuff tendinitis (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Shoulder pain reduction, Range of motion improvement and 1 more. Started Aug 2023; status: completed.
02
Drugs
ketorolacmethylprednisolone
03
Conditions
rotator cuff tendinitis
Beyond the preview
Go deeper on IRCT20230625058584N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230625058584N1.